tirzepatide fda label Grants a New Indication for Obesity Management What is OFF - LABEL
Description
These medications, often categorized as GLP-1 receptor agonists, offer significant benefits beyond weight reduction
Here, experts weigh in with mitigation strategies
Side effect bother was measured with the Functional Assessment of Chronic Illness Therapy (FACIT) GP5 item
Regularity and digestive comfort
